ClinicalTrials.gg
Not yet recruitingNCT07565025IJV-CIUpdated Aug 3, 2026

Internal Jugular Vein Collapsibility Index for Predicting Post-Induction Hypotension

An observational study in Hypotension, Anesthesia, General and Cholecystectomy, Laparoscopic, sponsored by University of Gaziantep. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by University of Gaziantep · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
42
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to investigate whether the Internal Jugular Vein Collapsibility Index (IJV-CI), measured via ultrasonography, can predict hypotension (low blood pressure) that occurs after the induction of general anesthesia. Researchers will measure the diameter of the internal jugular vein in patients before surgery and compare these measurements with the blood pressure changes during the first minutes of anesthesia. The goal is to determine if IJV-CI can be used as a reliable, non-invasive tool to identify patients at higher risk of developing anesthesia-induced hypotension.

Read the detailed description

Patients aged 18-65 scheduled for elective laparoscopic cholecystectomy under general anesthesia will be included in the study. Exclusion criteria are as follows: Obesity (BMI > 35 kg/m²), presence of Atrial Fibrillation or serious cardiac arrhythmia, history of neck surgery or any pathology preventing internal jugular vein measurement, advanced heart failure (Ejection Fraction \< 40%), severe valvular disease, peripheral vascular disease, emergency surgery, and refusal to participate in the study.

Upon arrival in the operating room, patients will be placed in a supine position. The Internal Jugular Vein (IJV) diameter will be monitored using a linear ultrasound probe during spontaneous breathing before anesthesia induction. The maximum and minimum diameters of the IJV during the respiratory cycle will be measured. The Internal Jugular Vein Collapsibility Index (IJV-CI) will be calculated using the following formula: [(IJV maximum diameter - IJV minimum diameter) / IJV maximum diameter] x 100.

Standard anesthesia induction will be performed. Non-invasive blood pressure and heart rate will be monitored and recorded at baseline (0 min), and at 1, 2, 3, 5, 7, 9, and 10 minutes following induction. Post-induction hypotension is defined as a decrease in mean arterial pressure (MAP) of more than 20% from the baseline value. The relationship between the pre-induction IJV-CI values and the development of hypotension during these specific time intervals will be statistically analyzed.

02

Conditions studied

  • Hypotension
  • Anesthesia, General
  • Cholecystectomy, Laparoscopic

Browse trials for

Keywords

  • Internal Jugular Vein
  • Collapsibility Index
  • IJV-CI
  • Ultrasonography
  • Post-induction Hypotension
  • Anesthesia Induction
  • Laparoscopic Cholecystectomy
  • Fluid Responsiveness
03

In context

Hypotension

885 studies on the registry are indexed under Hypotension; 195 are open to participants now.

This study's planned enrollment of 42 is below the median of 90 across 265 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

University of Gaziantep is the lead sponsor of 105 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of adult patients aged 18-65 who are scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia. Participants will be selected from patients who meet the ASA I-III physical status criteria. The study focuses on evaluating pre-induction internal jugular vein characteristics using routine clinical monitoring data in a perioperative setting.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-65 years.
  • Patients with ASA () physical status I, II, or III.
  • Patients scheduled to receive general anesthesia.
  • Patients scheduled for elective laparoscopic cholecystectomy.

Exclusion criteria

Exclusion Criteria:

  • Patients with obesity ( > 35 kg/m²).
  • Patients with Atrial Fibrillation or other serious cardiac arrhythmias.
  • Patients with a history of neck surgery or any pathology preventing Internal Jugular Vein (IJV) measurement.
  • Patients with advanced heart failure ( \< 40%).
  • Patients with severe valvular heart disease.
  • Patients with peripheral vascular disease.
  • Patients undergoing emergency surgery.
  • Patients who are unwilling to participate in the study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
42 participants (estimated)
Patient registry
No

Groups and cohorts

  • Hypotensive Group

    Patients who developed post-induction hypotension (MAP decrease \>20% or SBP \<90 mmHg). Pre-induction Internal Jugular Vein (IJV) ultrasonography was performed for statistical comparison.

    Diagnostic Test: IJV-CI Measurement

  • Non-hypotensive Group

    Patients aged 18-65 scheduled for elective laparoscopic cholecystectomy who remained hemodynamically stable (no MAP decrease \>20% or SBP \<90 mmHg) after standard anesthesia induction. Pre-induction IJV measurement was performed to evaluate its predictive capacity."

    Diagnostic Test: IJV-CI Measurement

Interventions

  • Diagnostic testIJV-CI Measurement

    Pre-induction Internal Jugular Vein (IJV) measurement will be performed using a linear ultrasound probe (5-12 MHz) while the patient is in the supine position. The IJV will be imaged in the transverse plane at the level of the cricoid cartilage. During spontaneous breathing, the maximum and minimum diameters of the vein will be recorded. The Collapsibility Index (IJV-CI) will be calculated using these measurements. This non-invasive assessment is performed immediately before the induction of general anesthesia to evaluate its predictive value for post-induction hypotension.

    Also known as: IJV-CI, Internal Jugular Vein Collapsibility Index, IJV Ultrasonography

06

What researchers measure

Primary outcomes

  1. Internal Jugular Vein Collapsibility Index (IJV-CI)

    Hypotension is defined as a decrease in Mean Arterial Pressure (MAP) of more than 20% from the baseline value. The predictive value of pre-induction IJV-CI for this occurrence will be assessed.Measurements will be recorded at 0, 1, 2, 3, 5, 7, 9, and 10 minutes following induction, but will stop if surgical incision occurs earlier than 10 minutes

    Time frame: Baseline (pre-induction) and every minute up to 10 minutes following induction or until surgical in

07

Study locations

1 site
  • Gaziantep University Sahinbey Research and Training Hospital
    Gaziantep, 27310, Turkey (Türkiye)
    • KÜBRA BAHAR TÜRKMEN, MD · Contactkbrabaharr@gmail.com · +90 (534) 061 74 44
    • ELZEM ŞEN, Associate Professor · Contactdrelzem@hotmail.com · +90 (532) 784 21 51
    • ELZEM ŞEN, Associate Professor · Principal investigator
    • KÜBRA BAHAR TÜRKMEN, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect patient confidentiality and privacy in accordance with local ethical committee guidelines and institutional data protection policies.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jan 2027, 4 months later.

Of 146 non-industry observational studies under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 25. This study's planned 4 months is below that.

Counting every sponsor, half of 151 studies reached it within 11 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2026
First posted
May 4, 2026
StartEst.
Aug 15, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Feb 2027
Last update
Aug 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07565025
Responsible party
Elzem SEN (Associate Professor, University of Gaziantep) — Principal investigator
First posted
May 4, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Aug 3, 2026

Study contacts

ELZEM ŞEN, Associate Professor
Contact
drelzem@hotmail.com
+90 (532) 784 21 52
Kübra Bahar Türkmen, MD
Contact
kbrabaharr@gmail.com
+90 (534) 061 74 44
ELZEM ŞEN, Associate Professor
principal investigator · Gaziantep University, Faculty of Medicine, Department of Anesthesiology and Reanimation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion